mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.004 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.005 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.005 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.006 |
mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
-0.48 |
0.007 |